Atorvastatin과 Calcium Channel Blocker 사용 환자에서의 콜키신 유발 급성 근육병증: 증례보고의 사례
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 권유하 | - |
dc.contributor.author | 강효정 | - |
dc.contributor.author | 이지훈 | - |
dc.contributor.author | 김동휘 | - |
dc.contributor.author | 황미령 | - |
dc.date.accessioned | 2021-09-08T22:11:39Z | - |
dc.date.available | 2021-09-08T22:11:39Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 2733-6581 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121161 | - |
dc.description.abstract | Myopathy is a rare side effect of chronic colchicine therapy, most often occurring in patients with chronic renal failure. Colchicine and 3-hydroxy-3-methy-glutaryl coenzyme A (HMG-CoA) reductase inhibitors are well known to cause myopathy. We report the case of a patient with chronic renal failure who had been taking atorvastatin and calcium channel blocker and developed acute weakness 7 days after the initiation of colchicines therapy for gouty attack. A 58-year-old woman on colchicine 0.6 mg twice a day for 7 days, developed subacute onset of painless proximal muscle weakness with elevation of creatine phosphokinase (CPK) level. Nerve conduction studies revealed a mild axonal and demyelinating neuropathy affecting the arms and legs and needle electromyography showed non-specific findings indicating myopathy. After withdrawal of colchicine, serum CPK levels returned to normal and her weakness resolved over a period. In our patient, neurological toxicity was induced and accerlated by coadministration of colchicines with atorvastatin and calcium channel blocker in the presence of impaired renal function. Colchicine is to be used with caution in patients with impaired renal function especially in those who are concomitantly administering other drugs that may further inhibit colchicine clearance. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한근전도전기진단의학회 | - |
dc.title | Atorvastatin과 Calcium Channel Blocker 사용 환자에서의 콜키신 유발 급성 근육병증: 증례보고의 사례 | - |
dc.title.alternative | A Case of Colchicine Induced Acute Myopathy in Atorvastatin and Calcium Channel Blocker User | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김동휘 | - |
dc.contributor.affiliatedAuthor | 황미령 | - |
dc.identifier.doi | 10.18214/jkaem.2009.11.2.169 | - |
dc.identifier.bibliographicCitation | 대한근전도 전기진단의학회지, v.11, no.2, pp.169 - 173 | - |
dc.relation.isPartOf | 대한근전도 전기진단의학회지 | - |
dc.citation.title | 대한근전도 전기진단의학회지 | - |
dc.citation.volume | 11 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 169 | - |
dc.citation.endPage | 173 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001450306 | - |
dc.description.journalClass | 3 | - |
dc.subject.keywordAuthor | Colchinice | - |
dc.subject.keywordAuthor | Atorvastatin | - |
dc.subject.keywordAuthor | Myopathy | - |
dc.subject.keywordAuthor | Neuropathy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.